Axumin (fluciclovine F-18)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Axumin (fluciclovine F-18), covering 2024-11-29 to 2025-11-05. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT [Phase 1]